GENPOINT AS Company Profile
GENPOINT® AS, an innovative biotechnology company founded in 1998 with headquarters in Oslo, NORWAY. The largest investors (93,7%) are: Startfondet ASA, Biovekst AS, and Braganza As. Genpoint® AS has received significant research funding from the Norwegian Research Council from the start. The company currently employs 16 people.
Genpoint specialises in preparation of DNA/ RNA from bacteria, viruses, parasites and human cells in difficult biological samples like urine, sputum, and faeces.
The company delivers complete automated solutions for isolation of DNA/RNA of among others STI, MRSA and tuberculosis.
Genpoint also deliver custom made solutions to OEM partners.
The technologies aim to support the users' reproducibility, productivity and effectiveness by improving speed, reliability, ease of use, and reduction of costs. Genpoint's commercial partners will thus get better products and improve their competitive position.
Phone: 47 22026565
Fax: 47 22026566
Drugs and Medications
In this study, 5 different commercial DNA extraction systems were tested on a stool sample collection containing 81 clinical stool specimens that were culture-positive for diarrheagenic Escherichia co...
GENPOINT® AS, an innovative biotechnology company founded in 1998 with headquarters in Oslo, NORWAY. The largest investors (93,7%) are: Startfondet ASA, Biovekst AS, and Braganza As. Genpoint® AS ha...
More Information about "GENPOINT AS" on BioPortfolio
We have published hundreds of GENPOINT AS news stories on BioPortfolio along with dozens of GENPOINT AS Clinical Trials and PubMed Articles about GENPOINT AS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GENPOINT AS Companies in our database. You can also find out about relevant GENPOINT AS Drugs and Medications on this site too.